EGFR and ovarian carcinoma: MEK/ERK1/2 was activated by FAM83D protein and can up-regulate the expression of MMP2 and activate EGFR through a ligand-dependent mechanism, thereby leading to the invasion and metastasis of ovarian cancer cells 120.